Center-Authored Papers

Filters: Author is O'Meara, Megan M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Shared Resources
Khera N, Jinneman J, Storer BE, Heimfeld S, O'Meara MM, Chauncey TR, Lee SJ, Linenberger ML.  2012.  Limiting the Daily Total Nucleated Cell Dose of Cryopreserved Peripheral Blood Stem Cell Products for Autologous Transplantation Improves Infusion-Related Safety with No Adverse Impact on Hematopoietic Engraftment.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(2):220-228. Abstract
Research Trials Office Core Facility - Biostatistics Service
Khera N, Jinneman J, Storer BE, Heimfeld S, O'Meara MM, Chauncey TR, Lee SJ, Linenberger ML.  2012.  Limiting the Daily Total Nucleated Cell Dose of Cryopreserved Peripheral Blood Stem Cell Products for Autologous Transplantation Improves Infusion-Related Safety with No Adverse Impact on Hematopoietic Engraftment.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(2):220-228. Abstract
November 2013
Disis ML, Gad E, Herendeen DR, Lai VP-, Park KH, Cecil DL, O'Meara MM, Treuting PM, Lubet RA.  2013.  A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease.. Cancer prevention research (Philadelphia, Pa.). 6(12):1273-82. Abstract
January 2014
Gopal AK, Bartlett NL, Forero-Torres A, Younes A, Chen R, Friedberg JW, Matous JV, Shustov AR, Smith SE, Zain J et al..  2013.  Brentuximab Vedotin in Patients Aged 60 Years or Older with Relapsed or Refractory CD30+ Lymphomas: A Retrospective Evaluation of Safety and Efficacy.. Leukemia & lymphoma. Abstract
Genomics Core Facility
Disis ML, Gad E, Herendeen DR, Lai VP-, Park KH, Cecil DL, O'Meara MM, Treuting PM, Lubet RA.  2013.  A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease.. Cancer prevention research (Philadelphia, Pa.). 6(12):1273-82. Abstract
Flow Cytometry Core Facility
Khera N, Jinneman J, Storer BE, Heimfeld S, O'Meara MM, Chauncey TR, Lee SJ, Linenberger ML.  2012.  Limiting the Daily Total Nucleated Cell Dose of Cryopreserved Peripheral Blood Stem Cell Products for Autologous Transplantation Improves Infusion-Related Safety with No Adverse Impact on Hematopoietic Engraftment.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(2):220-228. Abstract
Clinical Research Division
Gopal AK, Bartlett NL, Forero-Torres A, Younes A, Chen R, Friedberg JW, Matous JV, Shustov AR, Smith SE, Zain J et al..  2013.  Brentuximab Vedotin in Patients Aged 60 Years or Older with Relapsed or Refractory CD30+ Lymphomas: A Retrospective Evaluation of Safety and Efficacy.. Leukemia & lymphoma. Abstract
Disis ML, Gad E, Herendeen DR, Lai VP-, Park KH, Cecil DL, O'Meara MM, Treuting PM, Lubet RA.  2013.  A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease.. Cancer prevention research (Philadelphia, Pa.). 6(12):1273-82. Abstract
Khera N, Jinneman J, Storer BE, Heimfeld S, O'Meara MM, Chauncey TR, Lee SJ, Linenberger ML.  2012.  Limiting the Daily Total Nucleated Cell Dose of Cryopreserved Peripheral Blood Stem Cell Products for Autologous Transplantation Improves Infusion-Related Safety with No Adverse Impact on Hematopoietic Engraftment.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(2):220-228. Abstract
Center-Authored Paper
Khera N, Jinneman J, Storer BE, Heimfeld S, O'Meara MM, Chauncey TR, Lee SJ, Linenberger ML.  2012.  Limiting the Daily Total Nucleated Cell Dose of Cryopreserved Peripheral Blood Stem Cell Products for Autologous Transplantation Improves Infusion-Related Safety with No Adverse Impact on Hematopoietic Engraftment.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(2):220-228. Abstract
Disis ML, Gad E, Herendeen DR, Lai VP-, Park KH, Cecil DL, O'Meara MM, Treuting PM, Lubet RA.  2013.  A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease.. Cancer prevention research (Philadelphia, Pa.). 6(12):1273-82. Abstract
2013
Gopal AK, Bartlett NL, Forero-Torres A, Younes A, Chen R, Friedberg JW, Matous JV, Shustov AR, Smith SE, Zain J et al..  2013.  Brentuximab Vedotin in Patients Aged 60 Years or Older with Relapsed or Refractory CD30+ Lymphomas: A Retrospective Evaluation of Safety and Efficacy.. Leukemia & lymphoma. Abstract
Disis ML, Gad E, Herendeen DR, Lai VP-, Park KH, Cecil DL, O'Meara MM, Treuting PM, Lubet RA.  2013.  A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease.. Cancer prevention research (Philadelphia, Pa.). 6(12):1273-82. Abstract
2012
Khera N, Jinneman J, Storer BE, Heimfeld S, O'Meara MM, Chauncey TR, Lee SJ, Linenberger ML.  2012.  Limiting the Daily Total Nucleated Cell Dose of Cryopreserved Peripheral Blood Stem Cell Products for Autologous Transplantation Improves Infusion-Related Safety with No Adverse Impact on Hematopoietic Engraftment.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(2):220-228. Abstract